Servier UK appoints new chief executive

Dr Arnaud Lallouette has been appointed chief executive of Servier Laboratories, the UK subsidiary of the French-based pharma firm, after current chief exec Mike Sumpter moved to a new role within the company.

Dr Lallouette has been with Servier Group for twenty years, and will make the transition from general manager of Servier Scandinavia on January 1. He will have responsibility for Servier UK’s return to the diabetes arena, and Servier UK’s first launch of an oncology product.

Meanwhile Sumpter will be taking up a new role at the company’s headquarters in Paris, as head of alliance management, following seven years as chief exec of Servier UK, before which he spent seven years as head of Servier Canada. He will be leading a team tasked with effectively managing Servier’s external collaborations. Following the relocation he will also step down from his position from the board of management at the ABPI.

Sumpter says: “As business development and licensing assumes an increasing role within Servier’s activities, effective alliance management will be key to optimal outcomes for these collaborations.”